← back to search

Richard J. Glassock

University of Southern California · US
Area of research
Nephrology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Renal Diseases and Glomerulopathies, Chronic Kidney Disease and Diabetes, Dialysis and Renal Disease Management, and Vasculitis and related conditions.
h-index
73
citations
24,968
works
505
NIH funding
primary concept
Medicine
email

Recent publications

Expert Discussion on Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Challenges and Considerations.
2025cited by 4position: contributordoi
Semaglutide and kidney function: direct kidney protection or an artifact?
Kidney International 2025cited by 4position: contributordoi
International Consortium to Classify Ageing-related Pathologies (ICCARP) senescence definitions: achieving international consensus
GeroScience 2025cited by 4position: middledoi
Artificial Intelligence in Clinical Trials: A Comparative Study With Nephrologists in Prescreening
Kidney International Reports 2025cited by 2position: contributordoi
An Expert Opinion on Current and Future Treatment Approaches in IgA Nephropathy.
2025cited by 1position: contributordoi
Berger disease redux
Kidney International 2025cited by 0position: contributordoi
Correlation of Urinary Soluble CD163 Levels With Disease Activity and Treatment Response in IgA Nephropathy
Kidney International Reports 2024cited by 22position: middledoi
Defining an Ageing-Related Pathology, Disease or Syndrome: International Consensus Statement
medRxiv 2024cited by 2position: middledoi
Prognostic Scoring in IgA Vasculitis.
2024cited by 1position: contributordoi
In Memoriam of Barry M. Brenner, MD
Journal of the American Society of Nephrology 2024cited by 1position: contributordoi
The renal function trajectory in clinical trial design: challenges and opportunities
Kidney International 2024cited by 1position: contributordoi
Mayo Clinic consensus report on membranous nephropathy: proposal for a novel classification
Kidney International 2023cited by 106position: middledoi
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification
Mayo Clinic Proceedings 2023cited by 43position: middledoi
From inflammation to renal fibrosis: A one-way road in autoimmunity?
Autoimmunity Reviews 2023cited by 30position: lastdoi
Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy
JAMA 2022cited by 317position: middledoi
Americentrism in estimation of glomerular filtration rate equations
Kidney International 2022cited by 27position: contributordoi
"Presumed" Primary Focal Segmental Glomerulosclerosis: A Novel Nuance for Steroid Therapy.
2022cited by 3position: contributordoi
Molecular Characterization of Membranous Nephropathy: <i>Quo Vadis?</i>
2022cited by 0position: contributordoi
In remembrance of Arthur H. Cohen, MD (1942–2022)
Kidney International 2022cited by 0position: contributordoi
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
Kidney International 2021cited by 768position: middledoi
Therapeutic trials in adult FSGS: lessons learned and the road forward
Nature Reviews Nephrology 2021cited by 116position: middledoi
The Kidney in Normal Aging
Clinical Journal of the American Society of Nephrology 2021cited by 43position: middledoi
The Therapeutic Evaluation of Steroids in IgA Nephropathy Global (TESTING) Study: Trial Design and Baseline Characteristics
American Journal of Nephrology 2021cited by 31position: middledoi
A Validation of the 2018 Revision of International Society of Nephrology/Renal Pathology Society Classification for Lupus Nephritis: A Cohort Study from China
American Journal of Nephrology 2020cited by 29position: middledoi
CKD: A Call for an Age-Adapted Definition
Journal of the American Society of Nephrology 2019cited by 351position: middledoi
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2019cited by 257position: middledoi
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Kidney International 2019cited by 185position: middledoi
Prevention of complications from use of conventional immunosuppressants: a critical review
Journal of Nephrology 2019cited by 92position: lastdoi
The association of microhematuria with mesangial hypercellularity, endocapillary hypercellularity, crescent score and renal outcomes in immunoglobulin A nephropathy
Nephrology Dialysis Transplantation 2019cited by 42position: middledoi
Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach
Journal of the American Society of Nephrology 2018cited by 302position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 12 papers (2022–2025)Andrew D. Rule · Mayo Clinic11 papers (2012–2021)Pierre Delanaye · Hôpital Bichat-Claude-Bernard6 papers (2015–2019)Fernando C. Fervenza · The Ohio State University Wexner Medical Center6 papers (2012–2021)Sanjeev Sethi · Royal College of Surgeons in Ireland5 papers (2016–2023)Hans Pottel · KU Leuven5 papers (2016–2022)Björn O. Eriksen · University Hospital of North Norway3 papers (2016–2019)Christophe Mariat · Institute Cancer De La Loire Lucien Neuwirth3 papers (2016–2019)Aleksandar Đenić · Mayo Clinic3 papers (2015–2021) · 3 papers (2016–2021)Toralf Melsom · University Hospital of North Norway3 papers (2016–2019)Elke Schäeffner · Humboldt-Universität zu Berlin3 papers (2016–2019)Laurence Dubourg · Université Claude Bernard Lyon 13 papers (2016–2019)Fernando C. Fervenza · The Ohio State University Wexner Medical Center2 papers (2022–2022)Natalie Ebert · Freie Universität Berlin2 papers (2016–2016)Edmund J. Lamb · East Kent Hospitals University NHS Foundation Trust2 papers (2016–2016)David G. Warnock · University of Alabama at Birmingham2 papers (2013–2016) · 2 papers (2016–2016) · 2 papers (2016–2018)Kitty J. Jager · Indiana University – Purdue University Indianapolis2 papers (2017–2019)